Melissa Bondy was named chair of the Department of Epidemiology and Population Health and associate director for population sciences at the Stanford Cancer Institute. The appointment takes effect Oct. 1.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
